Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities
METABOLISM-CLINICAL AND EXPERIMENTAL, vol.64, no.9, pp.1086-1095, 2015 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 64 Issue: 9
- Publication Date: 2015
- Doi Number: 10.1016/j.metabol.2015.06.004
- Journal Name: METABOLISM-CLINICAL AND EXPERIMENTAL
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1086-1095
- Keywords: APL, Diabetes, Hepatic steatosis, Hypertriglyceridemia, Insulin resistance
- Dokuz Eylül University Affiliated: Yes
Abstract
Objective. Acquired partial lipodystrophy (APL) is a rare disorder characterized by progressive selective fat loss. In previous studies, metabolic abnormalities were reported to be relatively rare in APL, whilst they were quite common in other types of lipodystrophy syndromes.